Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes (Q44559076)

4 December 2017

Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes (English)

1 reference

4 December 2017

0 references

0 references

1 reference

1 reference

Gianluca Perseghin

1

1 reference

4 December 2017

Guido Lattuada

2

1 reference

4 December 2017

Massimo Danna

3

1 reference

4 December 2017

Lucia Piceni Sereni

4

1 reference

4 December 2017

Paola Maffi

5

1 reference

4 December 2017

Francesco De Cobelli

6

1 reference

4 December 2017

Alberto Battezzati

7

1 reference

4 December 2017

Antonio Secchi

8

1 reference

4 December 2017

Alessandro Del Maschio

9

1 reference

4 December 2017

Livio Luzi

10

1 reference

4 December 2017

21 August 2003

1 reference

American Journal of Physiology - Endocrinology and Metabolism

4 December 2017

1 reference

4 December 2017

285

1 reference

4 December 2017

E1174-81

1 reference

4 December 2017

6

1 reference

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

4 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Glucagon increases glutamine uptake without affecting glutamine release in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Fatty acid oxidation and the regulation of malonyl-CoA in human muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Endogenous glucose production is inhibited by the adipose-derived protein Acrp30

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Insulin-Mediated Glucose Disposal in Type I Diabetes: Evidence for Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Intramuscular triglyceride content is increased in IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Adiponectin is not altered with exercise training despite enhanced insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Fuel selection in human skeletal muscle in insulin resistance: a reexamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

The perils of portliness: causes and consequences of visceral adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Insulin resistance and insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Cellular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Natural course of insulin resistance in type I diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00279.2003

Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1152/AJPENDO.1999.276.5.E977

Identifiers

DOI

10.1152/AJPENDO.00279.2003

1 reference

4 December 2017

1 reference